Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria P Yavropoulou

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Peptides|October 6, 2009
Effect of intracerebroventricular infusion of neurotensin in glucose-dependent insulinotropic peptide secretion in dogsMaria P Yavropoulou, Kalliopi Kotsa, Isaak Kesisoglou, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2025
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trialPolyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
Hormones (Athens, Greece)|March 28, 2012
Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6Anna Maladaki, Maria P Yavropoulou, Kalliopi Kotsa, et al.
Hormones (Athens, Greece)|April 17, 2020
Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyPolyzois Makras, Maria P Yavropoulou, Evanthia Kassi, et al.
Maturitas|April 9, 2021
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerationsStergios A Polyzos, Athanasios D Anastasilakis, Zoe A Efstathiadou, et al.
Hormones (Athens, Greece)|February 22, 2017
Severe osteoporosis with multiple spontaneous vertebral fractures in a young male carrying triple polymorphisms in the vitamin D receptor, collagen type 1, and low-density lipoprotein receptor-related peptide 5 genesMaria P Yavropoulou, Panagoulia Kollia, Dimitris Chatzidimitriou, et al.
Acta Bio-Medica : Atenei Parmensis|June 16, 2023
Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine)Ploutarchos Tzoulis, Maria P Yavropoulou, Atanas Banchev, et al.
The Journal of Contemporary Dental Practice|January 10, 2022
Aggravated Dental and Periodontal Status in Patients with Sickle Cell Disease and Its Association with Serum FerritinSotiria Davidopoulou, Maria Pikilidou, Maria P Yavropoulou, et al.
Bone Reports|February 20, 2026
Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Journal of Clinical Medicine|January 7, 2021
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative ReviewAthanasios D Anastasilakis, Polyzois Makras, Maria P Yavropoulou, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Peptides|October 6, 2009
Effect of intracerebroventricular infusion of neurotensin in glucose-dependent insulinotropic peptide secretion in dogsMaria P Yavropoulou, Kalliopi Kotsa, Isaak Kesisoglou, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2025
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trialPolyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
Hormones (Athens, Greece)|March 28, 2012
Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6Anna Maladaki, Maria P Yavropoulou, Kalliopi Kotsa, et al.
Hormones (Athens, Greece)|April 17, 2020
Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyPolyzois Makras, Maria P Yavropoulou, Evanthia Kassi, et al.
Maturitas|April 9, 2021
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerationsStergios A Polyzos, Athanasios D Anastasilakis, Zoe A Efstathiadou, et al.
Hormones (Athens, Greece)|February 22, 2017
Severe osteoporosis with multiple spontaneous vertebral fractures in a young male carrying triple polymorphisms in the vitamin D receptor, collagen type 1, and low-density lipoprotein receptor-related peptide 5 genesMaria P Yavropoulou, Panagoulia Kollia, Dimitris Chatzidimitriou, et al.
Acta Bio-Medica : Atenei Parmensis|June 16, 2023
Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine)Ploutarchos Tzoulis, Maria P Yavropoulou, Atanas Banchev, et al.
The Journal of Contemporary Dental Practice|January 10, 2022
Aggravated Dental and Periodontal Status in Patients with Sickle Cell Disease and Its Association with Serum FerritinSotiria Davidopoulou, Maria Pikilidou, Maria P Yavropoulou, et al.
Bone Reports|February 20, 2026
Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Journal of Clinical Medicine|January 7, 2021
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative ReviewAthanasios D Anastasilakis, Polyzois Makras, Maria P Yavropoulou, et al.
Pageof 12